www.medskool.com
 

Google
 
Web www.MedSkool.Net
 
http://www.medskool.net/index.html
http://www.medskool.net/circulatory/index.html
http://www.medskool.net/excretory/index.html
http://www.medskool.net/integumentary/index.html
http://www.medskool.net/reproductive/index.html
http://www.medskool.net/respiratory/index.html
 
 
 
 
 
 
 
 

 

 
 

Infectious Diseases of the Respiratory System

 

·         The diagnosis of community acquired pneumonia is made based on clinical facts; biopsies are very infrequent and not commonly done because they are so invasive.  The clinical workup is dependent on the clinician, so make sure you’re thorough!

·         We are going to discuss 2 classes of infectious diseases of the lung:

o        Viral: This causes interstitial lung damage (to the alveolar septae).  The septae are full of cells making oxygen perfusion difficult, which results in dyspnea.

o        Bacterial: This is an intra-alveolar process causing damage to the alveoli, which also results in dyspnea.

o        Although both viral and bacterial pneumonia have the same clinical presentation (SOB, chest pain, malaise, fever, high WBC), the histological findings will differ.

 
Viral Lung Disease
(period of onset ~2 days)

·         This is characterized by interstitial pneumonitis, which interferes with oxygen diffusion causing SOB.

·         The 3 outcomes are resolution in approximately a week (most common), pulmonary fibrosis (scarring), and diffuse alveolar damage (uncommon, but seen in ARDS – acute respiratory distress syndrome).

o        If you look at the lungs of healthy patients who had pneumonia in the past, you can’t tell that they had a viral infection because of complete resolution.

o        Some patients do not resolve because they are very young, very old, debilitated, or the infection is so enormous that it can override the normal healthy response.

 This image shows the progression of viral pneumonia:
 

 

viral pneumonia
 

·         The 1st picture shows the alveolar membrane of a normal lung which is a thin, single-cell layer, allowing for good oxygen transfer from the lung into the capillaries.  The viral particles are seen in the alveolar space.

·         The 2nd picture shows the infection of Type I pneumocytes which are easily destroyed by the disease.  This process is called interstitial pneumonitis, and as I mentioned earlier, it resolves in about a week.

·         The 3rd picture shows hyperplastic Type II pneumocytes which try to adapt to the stimulus.  The thickened interstitium contains debris, edema, and inflammatory cells and the capillaries are dilated and congested.  This particular schematic also shows hyaline membrane.  Hyaline membrane is not normally seen patients who just have viral pneumonia; it’s seen as a consequence of patients who have unresolved pneumonia causing further complications.

·         (The difference between Type I & II pneumocytes was taken from the 2003 scribe notes, but wasn’t discussed in class.)


So what’s all this hype about the avian flu?  The reason for panic is because an infection with this agent causes the patient’s condition to degrade quickly.  Resolution is rare and most patients rapidly progress to ARDS which leads to death.   The patient has no time to develop symptoms before they’re very ill. 

The influenza epidemic (1917-18) which swept across the world killed over half-million people (more casualties than any of the World Wars or the Civil War.)  Attempts are being made to understand the genetic material of the virus behind the 1918 flu to prevent a recurrence of the epidemic.
 
 

Bacterial Lung Disease (S. aureus, S. pneumoniae, H. influenzae)

·         There are 2 types: lobar pneumonia (mainly caused by S. pneumonia) and bronchopneumonia (can be caused by all 3 agents).

streptococcus

·         The organism may be hard to visualize with Gram staining due to surrounding dead tissue, debris, WBCs, and RBCs.  The slide shows a nice view of a long chain of Strep among dead inflammatory cells.
 

·         Lobar Pneumonia

o        As mentioned before, S. pneumoniae is the etiological agent in 95% of the cases.  Klebsiella and other organisms can be the cause, but less frequently.

o        Part of the lobe or the entire lobe is involved, and it is unilateral.

o        The patients are usually debilitated or alcoholics, which compromises the host.

o        In the CXR you typically see a unilobar bulging fissure, abscess with cavity formation, and pleural effusion and empyema (pus in the pleural cavity).  Complete lobar consolidation is typically limited to one lobe and the patient complains of pleuritic chest pain in a focal area. 

o        One complication that could occur is that the organisms could spread to the other lobes causing bronchopneumonia of the other lung so the patient could present with this as well.  Additionally, the bacteria could easily disseminate through the blood to the heart and brain causing endocarditis or meningitis.

o        The hallmark of bacterial pneumonia (lobar and broncho) is that it’s an intra-alveolar process with acute inflammatory (suppurative) infiltrate that commonly results in destroyed alveoli septae (even though the septae aren’t involved in the inflammatory response), leading to scarring upon recovery.  As with viral pneumonia, the 3 possible outcomes of bacterial pneumonia are resolution, scarring, or progressive disease.

o        Other predisposing factors to developing lobar pneumonia include cirrhosis, renal failure, malignancy, diabetes, and sickle cell disease.

o        It’s a very virulent disease with a high mortality rate (about 20%).  These patients need to be treated immediately with antibiotics.

·         Bronchopneumonia

o        Bronchopneumonia is the most common form of bacterial pneumonia.  As mentioned before, the major causes are Staph, Strep, and H. influenzae.

o        Bronchopneumonia tends to be more focused with inflammation around the bronchioles while lobar pneumonia involves an entire lobe.

o        The pathological presentation is that of patchy consolidation, while there are other areas that are completely spared.  The consolidation is usually multilobar and bilateral.

o        The viral infection can become more disseminating and necrotizing, eventually resulting in complete consolidation of the lung (patches become confluent).

o        As the lung tries to resolve the infection, it goes through a series of processes.  The initial stage is an acute inflammatory exudate in alveoli and bronchi.  Some fibrin maybe present in the exudate.

§         This stage is followed by an acute congestive process called red hepatization.  The capillaries become dilated which leads to congestion and blood in the area (hyperemia).  Red hepatization is characterized by diffuse, homogeneous consolidation of PMNs & macrophages (to clear out the lung), fibrin, and RBCs in the alveoli.  The lung becomes red, hard, and liver-like.

§         Grey hepatization appears 2-3 days after red hepatization when more macrophages come in to consume the inflammatory cells, RBCs, and bacteria.  The lung remains firm, but is grey, dry, granular due to the resolution process and increased fibrin deposition.  Following this, complete resolution results.  Antibiotics help to speed up the process.        

broncopneumonia

Gross cut of lung.  The dark, tube-like structures are the bronchioles.  The black pigmentation is caused by pollutants trapped in the bronchioles.  The affected bronchioles are surrounded by white patches which represent inflammation.  The spared bronchioles are surrounded in red tissue (lack inflammation).  In time, the inflammation can become confluent leaving you with a completely consolidated lung.


Back to the Respiratory System Index
 

 


Navigation:

MedSkool.Net Home - Circulatory - Excretory - Integumentary - Respiratory
MedSkool.Net Sitemap
 

 

All Content provided on or through MedSkool.Net (i) is provided for informational purposes only, (ii) is not a substitute for professional medical advice, care, diagnosis or treatment, and (iii) is not designed to promote or endorse any medical practice, program or agenda or any medical tests, products or procedures. The Site does not contain information about all diseases, nor does this Site contain all information that may be relevant to a particular medical or health condition. You should not use any Content for diagnosing or treating a medical or health condition. You should carefully read all information provided by the manufacturers of any products advertised or promoted on or through the Site and displayed on or in the associated product packaging and labels before purchasing and/or using such products. If you have or suspect that you have a medical problem, you should contact your professional healthcare provider through appropriate means. You agree that you will not under any circumstances disregard any professional medical advice or delay in seeking such advice in reliance on any Content provided on or through the Site. Reliance on any such Content is solely at your own risk.    Full Disclaimer

Copyright © 2006 www.MedSkool.Net - All Rights Reserved - Trademarks used herein are property of their respective owners